[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fcLLcdlO3IgPGs5W5gOXK1CCkl862CTgBBm_s7WkFYkc":8,"$fjuE5xXIV-vOyKsEIc4KzqjOgnpIUkd48uCPsrRuBVEE":55,"$fg4m9O5h3QwQJmR_W1xG-G7Zg_hu0OTQdtMTZoMLG1tE":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},54574,867193,[],"https://ystcdn.venuertc.com/medical/ystApp/RrM5xDxVhrr4fpz5auCKTz2MWSI8FfTX.png","马晓阳","安丘市人民医院","普外科","住院医师",311,0,"乳腺癌早期治疗：表柔比星 + 环磷酰胺化疗方案的实用用药指南","","https://ystcdn.venuertc.com/venue/AI/3d549a2b-0d62-4f73-8738-faadd00624f9.jpg","\u003Cdiv class=\"drug-guide-container\">\n  \u003Ch1 id=\"material_title\" class=\"drug-guide-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    乳腺癌早期治疗：表柔比星 + 环磷酰胺化疗方案的实用用药指南\n  \u003C/h1>\n  \n  \u003Cdiv class=\"drug-guide-section drug-guide-section-bg1\">\n    \u003Ch2 class=\"drug-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      💊 表柔比星和环磷酰胺简介\n    \u003C/h2>\n    \u003Cp>\n      化疗方案中，表柔比星（Epirubicin）和环磷酰胺（Cyclophosphamide）是经常被联合使用的药品。表柔比星属于蒽环类抗肿瘤药，环磷酰胺则是一种烷化剂。这两种药品常用于多种方案中，尤其在辅助治疗过程中占据重要地位。选用这类化疗药，掌握正确的用药方式和必要的注意细节有助于提升疗效并减少副作用风险。今天，我们就为大家详细整理了7个关键用药细节，帮助你用得明白、更放心。\n    \u003C/p>\n  \u003C/div>\n  \n  \u003Cdiv class=\"drug-guide-section drug-guide-section-bg2\">\n    \u003Ch2 class=\"drug-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">1️⃣ 化疗药品成分、规格与剂型\u003C/h2>\n    \u003Cp>\n      \u003Cstrong>表柔比星：\u003C/strong> 一般以注射剂型为主，成分为盐酸表柔比星，常用规格有10mg、20mg、50mg的小瓶装。针对不同治疗方案使用剂量会有所调整。\u003Cbr>\n      \u003Cstrong>环磷酰胺：\u003C/strong> 也以注射剂和口服制剂为主，注射用规格常见为200mg、500mg、1g粉针瓶装，口服片剂则多见为50mg。\n    \u003C/p>\n    \u003Cdiv class=\"drug-guide-tips\">\n      正确做法：每次化疗前，确认化疗单及药品瓶身上的规格与用药计划一致，防止剂量差错。避免自行折算或更换药品剂型，必须由医师和药师统一管理。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"drug-guide-section drug-guide-section-bg3\">\n    \u003Ch2 class=\"drug-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">2️⃣ 作用机制简析\u003C/h2>\n    \u003Cp>\n      \u003Cstrong>表柔比星\u003C/strong> 通过嵌入 DNA 结构、抑制拓扑异构酶 II 活性，使癌细胞分裂受阻，从而发挥效力。\u003Cbr>\n      \u003Cstrong>环磷酰胺\u003C/strong> 则是通过与 DNA 直接结合，形成交联结构，导致细胞分裂无法继续并最终凋亡。\n    \u003C/p>\n    \u003Cdiv class=\"drug-guide-tips\">\n      作用机制理解有助于理解用药的重要性，但具体疗效应遵循医生和临床方案个体化制定。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"drug-guide-section drug-guide-section-bg4\">\n    \u003Ch2 class=\"drug-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">3️⃣ 用法用量及操作细节\u003C/h2>\n    \u003Cp>\n       表柔比星和环磷酰胺多以周期性静脉输注完成。\u003Cbr>\n       \u003C/p>\u003Cul class=\"drug-guide-ul\">\n         \u003Cli>通常一个周期为21天，表柔比星和环磷酰胺于同一天输注。\u003C/li>\n         \u003Cli>输注需由专业人员在肿瘤科病房操作，严格监测输液速度和反应。\u003C/li>\n         \u003Cli>剂量需根据体表面积（mg/m²）个体化计算。\u003C/li>\n         \u003Cli>口服环磷酰胺时，需足量饮水以减少泌尿道损伤。\u003C/li>\n       \u003C/ul>\n    \u003Cp>\u003C/p>\n    \u003Cdiv class=\"drug-guide-tips\">\n      正确做法：遵循主治医师制定的化疗表和操作流程，任何剂量调整必须经过医生审批，严禁自行增减剂量或更改周期时程。\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"drug-guide-section drug-guide-section-bg5\">\n    \u003Ch2 class=\"drug-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">4️⃣ 用药过程的注意事项\u003C/h2>\n    \u003Cp>\n      \u003C/p>\u003Cul class=\"drug-guide-ul\">\n        \u003Cli>化疗当天及化疗后24小时内，建议多饮水，并避免与含酒精、刺激性饮料共同服用。\u003C/li>\n        \u003Cli>表柔比星有潜在心脏毒性风险，治疗期间需定期心脏功能监测（如心电图、心脏超声）。\u003C/li>\n        \u003Cli>环磷酰胺易引起膀胱刺激，使用时注意汇报尿液异常等情况。\u003C/li>\n        \u003Cli>任何用药前发生过敏或不良反应者，必须提前告知医护人员。已知对蒽环类药物（如多柔比星脂质体）过敏者，需要特别警惕。\u003C/li>\n      \u003C/ul>\n    \u003Cp>\u003C/p>\n    \u003Cdiv class=\"drug-guide-tips\">\n      特别提醒：化疗期间，出现皮肤、呼吸道明显不适，应及时中止用药并留院观察，防止严重过敏反应。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"drug-guide-section drug-guide-section-bg6\">\n    \u003Ch2 class=\"drug-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">5️⃣ 药物相互作用指南\u003C/h2>\n    \u003Cp>\n      两药联合应用时，需考虑与其他药品的潜在交互：\n      \u003C/p>\u003Cul class=\"drug-guide-ul\">\n        \u003Cli>表柔比星勿与心脏毒性药物（如蒽环类其他药品、曲妥珠单抗）联合使用，以免加重心脏负担。\u003C/li>\n        \u003Cli>环磷酰胺遇生产速效肝酶诱导药（酮康唑、苯妥英钠等）时，效应可能增强或延长，产生更多副作用。\u003C/li>\n        \u003Cli>常规降压药、抗生素、护胃药与化疗期间用药需分时段服用，防止吸收干扰与额外负担。\u003C/li>\n      \u003C/ul>\n    \u003Cp>\u003C/p>\n    \u003Cdiv class=\"drug-guide-tips\">\n      正确做法：化疗期间维持完整的药物清单，每次门诊提前让医生知晓正在服用的全部药物，特殊药品需单独管理或调整。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"drug-guide-section drug-guide-section-bg7\">\n    \u003Ch2 class=\"drug-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">6️⃣ 常见不良反应与处理\u003C/h2>\n    \u003Cp>\n      化疗药品有一定副作用风险，临床研究显示，表柔比星和环磷酰胺化疗方案中，最常见不良反应为白细胞减少、恶心呕吐、脱发、乏力及偶见皮肤变色。表柔比星还可能引起心脏损伤，环磷酰胺则有可能出现泌尿系统反应。\n      \u003Cbr>\n      \u003Cspan class=\"drug-guide-emoji\">⚠️\u003C/span> 正确做法：\n      \u003C/p>\u003Cul class=\"drug-guide-ul\">\n        \u003Cli>按计划定期做血常规和肝肾功能检查，发现异常及时报告。\u003C/li>\n        \u003Cli>有恶心、呕吐症状，可在医嘱下加用止吐药辅助。\u003C/li>\n        \u003Cli>如出现全身皮疹、呼吸困难、心悸等明显反应，必须立即停药和就医。\u003C/li>\n        \u003Cli>若口腔或泌尿系统有刺激感，合理饮水；严重者按医生建议调整用药。\u003C/li>\n      \u003C/ul>\n      若不良反应持续，应暂缓下周期化疗，至恢复后再启动下一周期。\n    \u003Cp>\u003C/p>\n  \u003C/div>\n  \n  \u003Cdiv class=\"drug-guide-section drug-guide-section-bg8\">\n    \u003Ch2 class=\"drug-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">7️⃣ 特殊人群用药需知\u003C/h2>\n    \u003Cp>\n      \u003C/p>\u003Cul class=\"drug-guide-ul\">\n        \u003Cli>老年人需降低表柔比星总剂量，关注心功能与肾脏状态，建议每周期复查心脏超声。\u003C/li>\n        \u003Cli>孕妇、哺乳期女性禁用该化疗方案，因有致畸和泌乳通道排泄风险。\u003C/li>\n        \u003Cli>肝、肾功能不足患者，应调整药物剂量，防止毒性蓄积。\u003C/li>\n        \u003Cli>已知有多柔比星脂质体过敏史者，转用表柔比星也需密切观察首次用药后的反应。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"drug-guide-emoji\">👨‍⚕️\u003C/span>\n      特别提醒：如遇上述情况，请务必提前将病史完整告知医生，根据专科意见调整用药。\n    \u003Cp>\u003C/p>\n  \u003C/div>\n  \n  \u003Cdiv class=\"drug-guide-section drug-guide-section-bg9\">\n    \u003Ch2 class=\"drug-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">8️⃣ 药品储存和管理要求\u003C/h2>\n    \u003Cp>\n      \u003C/p>\u003Cul class=\"drug-guide-ul\">\n        \u003Cli>表柔比星注射剂须保存在2～8℃的冰箱内，避免高温和直射光暴晒。\u003C/li>\n        \u003Cli>环磷酰胺注射剂应存放在阴凉、干燥处，口服剂型密闭防潮保存。\u003C/li>\n        \u003Cli>药品一旦开封，未用完部分须按医院流程处理，严禁自行存放或再次使用。\u003C/li>\n        \u003Cli>过期药品应按照医疗废弃物管理制度，统一交回药房处理。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"drug-guide-emoji\">🧊\u003C/span>\n      建议每次取药后，立即核对有效期和保存状态，确保药品活性和安全。\n    \u003Cp>\u003C/p>\n  \u003C/div>\n  \n  \u003Cdiv class=\"drug-guide-section drug-guide-section-bg10\">\n    \u003Ch2 class=\"drug-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">9️⃣ 化疗用药案例解析\u003C/h2>\n    \u003Cul class=\"drug-guide-case-list\">\n      \u003Cli>\n        有位患者使用多柔比星脂质体出现过敏后，经医师严格评估调整为表柔比星+环磷酰胺方案，避免了再次过敏，顺利完成疗程。\n      \u003C/li>\n      \u003Cli>\n        临床上，配合降压药长期化疗的高血压患者，需要加密血压动态监测，未出现异常波动，说明合理调整药物可以确保安全。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"drug-guide-tips\">\n      📝 案例启示：如有不良反应或合并历史，合理调整药品并配合专业监测是安全的关键。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"drug-guide-section drug-guide-section-bg11\">\n    \u003Ch2 class=\"drug-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">🔟 漏服、过量及紧急处理原则\u003C/h2>\n    \u003Cp>\n      \u003C/p>\u003Cul class=\"drug-guide-ul\">\n        \u003Cli>院内静脉化疗需定期预约，不得自行调整周期。若因特殊原因漏服，需由主治医生评估补发方案。\u003C/li>\n        \u003Cli>如丢失口服剂型或疑似用药过量，第一时间主动联系医师或药师，严禁自行补服或断药。\u003C/li>\n        \u003Cli>化疗期间严密记录每日服药情况，按医生日志签名核查，防止多剂量、漏剂量风险累积。\u003C/li>\n      \u003C/ul>\n      出现用药异常时，不要慌张，第一时间联系医疗团队。\n    \u003Cp>\u003C/p>\n  \u003C/div>\n  \n  \u003Cdiv class=\"drug-guide-section drug-guide-section-bg12\">\n    \u003Ch2 class=\"drug-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">✅ 重点回顾与安全宣言\u003C/h2>\n    \u003Cp>\n      表柔比星与环磷酰胺联合用药，具有疗效确切、方案成熟、安全保障措施多元的优势。但在用药过程中，牢牢把握：严格遵医嘱、警惕过敏及严重不良反应、关注药物交互及储存规范，是每一个疗程平稳顺利的基础。如果遇到特殊情况，不妨记录下服药日志，与药师和医生保持通畅联络，才能把风险降到最低，让化疗过程更加可控、放心。\n    \u003C/p>\n    \u003Cp>\n      \u003Cspan class=\"drug-guide-emoji\">🎯\u003C/span> 合理规范用药就是最好的健康保障。\n    \u003C/p>\n  \u003C/div>\n \n  \u003Cdiv class=\"drug-guide-section drug-guide-section-bg13\">\n    \u003Ch2 class=\"drug-guide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">📚 参考文献\u003C/h2>\n    \u003Cul class=\"drug-guide-ref-list\">\n      \u003Cli>\n        Alba, E., Lluch, A., & Ribelles, N. (2016). Anthracyclines in the treatment of early breast cancer. *The Breast*, 27, 151–155. https://doi.org/10.1016/j.breast.2016.03.011\n      \u003C/li>\n      \u003Cli>\n        Emadi, A., Jones, R. J., & Brodsky, R. A. (2009). Cyclophosphamide and cancer: golden anniversary. *Nature Reviews Clinical Oncology*, 6(11), 638–647. https://doi.org/10.1038/nrclinonc.2009.146\n      \u003C/li>\n      \u003Cli>\n        Blum, J.L. (2002). Safety of epirubicin in breast cancer: a review update. *The Oncologist*, 7(5), 410–419. https://doi.org/10.1634/theoncologist.7-5-410\n      \u003C/li>\n      \u003Cli>\n        Danesi, R., & Del Tacca, M. (2000). Pharmacokinetic optimization of cyclophosphamide. *Clinical Pharmacokinetics*, 38(6), 483-495. https://doi.org/10.2165/00003088-200038060-00001\n      \u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.drug-guide-container {\n  font-family:  \"Helvetica Neue\", Arial, \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei\", sans-serif;\n  background-color: #fbfaf8;\n  color: #303136;\n  padding: 42px 9% 50px 9%;\n  border-radius: 22px;\n  max-width: 980px;\n  margin: 32px auto 40px auto;\n  box-shadow: 0 6px 24px rgba(65,80,111,0.13);\n}\n.drug-guide-title {\n  font-size: 2.3em;\n  margin-bottom: 24px;\n  text-align: center;\n  color: #345180;\n  letter-spacing: 1.1px;\n  font-weight: 800;\n  background: linear-gradient(to right, #a3c1e4 0%, #f3e6cf 100%);\n  border-radius:18px 18px 0 0;\n  padding: 22px;\n}\n.drug-guide-section {\n  margin-bottom: 36px;\n  border-radius: 13px;\n  padding: 30px 22px 26px 25px;\n  font-size: 1.07em;\n  box-sizing: border-box;\n  box-shadow: 0 1px 10px rgba(52,97,165,0.05);\n}\n.drug-guide-subtitle {\n  font-size: 1.37em;\n  font-weight: 700;\n  color: #317c82;\n  margin-bottom: 18px;\n  letter-spacing: 0.7px;\n}\n.drug-guide-tips {\n  background: linear-gradient(to right, #f1f2fc 0%, #e9f6ee 100%);\n  color: #363875;\n  font-size:1em;\n  border-left:4px solid #a0b8df;\n  border-radius: 9px;\n  margin-top: 16px;\n  padding: 13px 18px;\n  line-height: 1.8em;\n  font-family:inherit;\n}\n.drug-guide-ul, .drug-guide-case-list {\n  margin: 9px 0 0 19px;\n  padding-left: 0;\n}\n.drug-guide-ul li,.drug-guide-case-list li {\n  line-height: 1.86;\n  margin-bottom: 2px;\n  list-style: disc inside;\n  font-size:1em;\n}\n.drug-guide-case-list {\n  color:#5c4e26;\n  background: #fcf7ee;\n  border-left:4px solid #ebd18f;\n  border-radius: 8px;\n  padding: 14px 19px;\n  margin-bottom:13px;\n}\n.drug-guide-ref-list {\n  margin-left: 7px;\n  color: #62728d;\n  font-size: 0.98em;\n  word-break:break-all;\n}\n.drug-guide-emoji {\n  font-size: 1.17em;\n  margin-right: 5px;\n}\n.drug-guide-section-bg1 { background: linear-gradient(90deg, #eaf7fa 45%, #f7f6f1 100%);}\n.drug-guide-section-bg2 { background: linear-gradient(90deg, #f3ecf2 2%, #eaf8fd 85%);}\n.drug-guide-section-bg3 { background: linear-gradient(88deg, #eaf8fd 25%, #eaf7ea 95%);}\n.drug-guide-section-bg4 { background: linear-gradient(90deg, #eaf7ea 43%, #f6f3e9 95%);}\n.drug-guide-section-bg5 { background: linear-gradient(90deg, #faf3e1 17%, #eaf8fd 95%);}\n.drug-guide-section-bg6 { background: linear-gradient(88deg, #f3ecf2 10%, #fcfbe9 89%);}\n.drug-guide-section-bg7 { background: linear-gradient(90deg, #e7ecf3 68%, #fcf7ee 100%);}\n.drug-guide-section-bg8 { background: linear-gradient(90deg, #fcfbe9 35%, #eaf8fd 100%);}\n.drug-guide-section-bg9 { background: linear-gradient(88deg, #f3ecf2 30%, #fcf7ee 100%);}\n.drug-guide-section-bg10 { background: linear-gradient(86deg, #fcf7ee 10%, #eaf7ea 90%);}\n.drug-guide-section-bg11 { background: linear-gradient(88deg,#eaf8fd 10%, #f3ecf2 100%);}\n.drug-guide-section-bg12 { background: linear-gradient(90deg,#f6f3e9 2%, #eaf8fd 100%);}\n.drug-guide-section-bg13 { background: linear-gradient(90deg,#eaf8fd 60%, #f7f6f1 100%);}\n@media (max-width: 769px){\n  .drug-guide-container{padding:18px 3%;}\n  .drug-guide-title{font-size:1.3em;}\n  .drug-guide-section{padding:13px;}\n}\n\u003C/style>\n","\u003Cdiv class=\"drug-guide-container\">\n  \u003Ch1 id=\"material_title\" class=\"drug-guide-title\" style=\"color: ",386,"2025-07-31 11:16:55","乳腺癌, 表柔比星, 环磷酰胺, 化疗, 药物使用指南","掌握表柔比星与环磷酰胺联合化疗的关键细节，提升疗效并减少副作用风险，让癌症治疗更加安心有效。","2025-08-05 13:46:49",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]